A newly published study reports that APC-deficient cancer cells may depend on a single metabolic enzyme for survival, revealing a potential strategy for selectively targeting tumours associated with ...
Sodium-glucose cotransporter-2 (SGLT2) inhibitors have revolutionized the therapeutic landscape of cardiometabolic and renal ...